Quantity size:
0.2ml
Concentration:
1mg/ml 癌症亮氨酸拉链下调因子1样蛋白抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
LDOC1 is a 146 amino acid nuclear protein that contains a leucine zipper-like motif and a proline-rich region that shares marked similarity with an SH3-binding domain. The protein localizes to the nucleus and is downregulated in some cancer cell lines. It is thought to regulate the transcriptional response mediated by the nuclear factor kB (NF-kB).癌症亮氨酸拉链下调因子1样蛋白抗体 The gene has been proposed as a tumor suppressor gene whose protein product may have an important role in the development and/or progression of some cancers. LDOC1L (Leucine zipper protein down-regulated in cancer cells-like), also known as MART6 (Mammalian retrotransposon-derived protein 6), is a 239 amino acid protein that belongs to the LDOC1 family.
癌症亮氨酸拉链下调因子1样蛋白抗体 Also known as:
dJ1033E15.2; DKFZp761O17121; LDOC1L; LDOCL_HUMAN; Leucine zipper down regulated in cancer 1 like; Leucine zipper protein down-regulated in cancer cells-like; Mammalian retrotransposon derived protein 6; Mammalian retrotransposon-derived protein 6; Mar6; Mart6; Protein LDOC1L.
Specificity:
●
Rabbit Polyclonal IgG,癌症亮氨酸拉链下调因子1样蛋白抗体 affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human LDOC1L.
●
Predicted Molecular Weight: 26kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
癌症亮氨酸拉链下调因子1样蛋白抗体 Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl313Mu01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl313Ra01抗凝血酶(AT)多克隆抗体Polyclonal Antibody to Antithrombin (AT)
kl820Hu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl820Mu01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl820Ra01凝血因子Ⅱ(F2)多克隆抗体Polyclonal Antibody to Coagulation Factor II (F2)
kl353Ge01晚期糖基化终末产物(AGE)多克隆抗体Polyclonal Antibody to Advanced Glycation End Product (AGE)
kl929Hu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Mu01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl929Ra01视黄醇结合蛋白4(RBP4)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 4, Plasma (RBP4)
kl367Hu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Mu01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl367Ra01视黄醇结合蛋白3(RBP3)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 3, Interstitial (RBP3)
kl377Hu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Mu01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl377Ra01视黄醇结合蛋白2(RBP2)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 2, Cellular (RBP2)
kl400Hu01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
kl400Mu01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
kl400Ra01视黄醇结合蛋白1(RBP1)多克隆抗体Polyclonal Antibody to Retinol Binding Protein 1, Cellular (RBP1)
kl372Hu01凝溶胶蛋白(GS)多克隆抗体Polyclonal Antibody to Gelsolin (GS)
kl372Mu01凝溶胶蛋白(GS)多克隆抗体Polyclonal Antibody to Gelsolin (GS)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话